&nbsp;

Oct 2020

Drug

lapatinib

Other Name(s): Tykerb®

Quick Link(s):

Jul 2025

Drug

leuprolide

Other Name(s): Lupron® , Lupron Depot® , Eligard®

Quick Link(s):

Dec 1969

Drug

lomustine

Other Name(s): CeeNU®

Quick Link(s):

Dec 1969

Drug

siltuximab

Other Name(s): Sylvant®

Quick Link(s):

Mar 2025

Drug

lenvatinib

Other Name(s): Lenvima®

Quick Link(s):

Sep 2023

Drug

lanreotide

Other Name(s): Somatuline® Autogel®

Quick Link(s):

Dec 1969

Drug

liposomal irinotecan

Other Name(s): Onivyde® (Baxalta Canada)

Quick Link(s):

Sep 2017

Regimen

LETR

Cancer Type:

Breast

Intent: Adjuvant

Funding:

ODB - General Benefit

letrozole

Drugs Used:

letrozole

Quick Link(s):

Regimen Monograph

Regimen

SUNI

Cancer Type:

Gastrointestinal,

Gastrointestinal Stromal Tumours,

Sarcoma,

GIST

Intent: Palliative

Funding:

Exceptional Access Program

SUNItinib - Unresectable or metastatic/recurrent Gastrointestinal Stromal Tumour, with specific criteria

Drugs Used:

SUNItinib

Quick Link(s):

Regimen Monograph

Oct 2020

Regimen

LETR

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

letrozole

Drugs Used:

letrozole

Quick Link(s):

Regimen Monograph

Regimen

LENA

Cancer Type:

Hematologic,

Myelodysplastic Syndrome (MDS)

Intent: Palliative

Funding:

ODB Limited Use

lenalidomide - For the treatment of patients with anemia due to myelodysplastic syndrome (MDS), according to clinical criteria

Drugs Used:

lenalidomide